Literature DB >> 20981769

Mouse models of cognitive disabilities in trisomy 21 (Down syndrome).

Pierre L Roubertoux1, Michèle Carlier.   

Abstract

Trisomy 21 (TRS21), also referred to as Down syndrome, occurs once in every 800-1,000 live births. It is the consequence of an extra copy of HSA21 that causes an imbalanced gene dose effect. TRS21 is the first known genetic cause of cognitive disability. The syndrome is complex, and includes various cardiac, immune, and bone disorders. Most of these signs are highly variable in expression but cognitive disability is the most constant characteristic of persons with TRS21. The syntenies that exist between HSA21 and three mouse chromosomes (MMU10, MMU16, and MMU17) offer the opportunity for a genotype-phenotype correlation. We present here the segmental trisomies available in the mouse and we discuss their contribution to the brain and cognitive phenotypes of TRS21.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20981769     DOI: 10.1002/ajmg.c.30280

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  10 in total

1.  Altered distribution of hippocampal interneurons in the murine Down Syndrome model Ts65Dn.

Authors:  Samuel Hernández-González; Raúl Ballestín; Rosa López-Hidalgo; Javier Gilabert-Juan; José Miguel Blasco-Ibáñez; Carlos Crespo; Juan Nácher; Emilio Varea
Journal:  Neurochem Res       Date:  2014-11-16       Impact factor: 3.996

2.  Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice.

Authors:  Ayelet Cooper; Gayane Grigoryan; Liora Guy-David; Michael M Tsoory; Alon Chen; Eitan Reuveny
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 3.  Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction.

Authors:  Jody Mayfield; Yuri A Blednov; R Adron Harris
Journal:  Int Rev Neurobiol       Date:  2015-06-22       Impact factor: 3.230

Review 4.  Antioxidants in Down syndrome.

Authors:  Ira T Lott
Journal:  Biochim Biophys Acta       Date:  2011-12-21

Review 5.  Mouse models for Down syndrome-associated developmental cognitive disabilities.

Authors:  Chunhong Liu; Pavel V Belichenko; Li Zhang; Dawei Fu; Alexander M Kleschevnikov; Antonio Baldini; Stylianos E Antonarakis; William C Mobley; Y Eugene Yu
Journal:  Dev Neurosci       Date:  2011-08-25       Impact factor: 2.984

6.  Evidence of altered age-related brain cytoarchitecture in mouse models of down syndrome: a diffusional kurtosis imaging study.

Authors:  Xingju Nie; Eric D Hamlett; Ann-Charlotte Granholm; Edward S Hui; Joseph A Helpern; Jens H Jensen; Heather A Boger; Heather R Collins; Maria F Falangola
Journal:  Magn Reson Imaging       Date:  2014-12-16       Impact factor: 2.546

7.  Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice.

Authors:  Chunhong Liu; Masae Morishima; Xiaoling Jiang; Tao Yu; Kai Meng; Debjit Ray; Annie Pao; Ping Ye; Michael S Parmacek; Y Eugene Yu
Journal:  Hum Genet       Date:  2013-12-22       Impact factor: 4.132

8.  Brain phenotype of transgenic mice overexpressing cystathionine β-synthase.

Authors:  Vinciane Régnier; Jean-Marie Billard; Sapna Gupta; Brigitte Potier; Stéphanie Woerner; Evelyne Paly; Aurélie Ledru; Sabrina David; Sabrina Luilier; Jean-Charles Bizot; Guido Vacano; Jan P Kraus; David Patterson; Warren D Kruger; Jean M Delabar; Jaqueline London
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

Review 9.  Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations.

Authors:  Katheleen J Gardiner
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

10.  Dental approach to craniofacial syndromes: how can developmental fields show us a new way to understand pathogenesis?

Authors:  Inger Kjær
Journal:  Int J Dent       Date:  2012-10-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.